Feed / DGX

Quest Diagnostics Incorporated

DGX

Healthcare · 233.18 -0.6% today

Jodie read · what matters now

Revenue increased 9.2% versus the comparable filing period.

The story is only the start. Jodie keeps watching the filing evidence, the companies connected to DGX, and whether its market group begins moving.

Latest storyNo Struct brief yetJodie is monitoring new filings.
Disclosed connections11 verified links9 additional receipts in Pro
Organic co-movement groupClinical Diagnostics Services · LeaderDiscovered from trading behaviour, not sector labels · Open group →

Latest filing assessment · baseline

Fundamentals strengthened in the latest filing

10-Q filed 2026-04-22 against the comparable filing from 2025-04-23.

constructive
OperationsconstructiveEvidence score +2
liquidityneutralEvidence score 0
valuationmixed

What improved

  • Revenue increased 9.2% versus the comparable filing period.
  • Operating margin improved 0.7 percentage points.

What weakened

No thresholded deterioration was identified.

Filing receipts

Revenue per requisition decreased by 1.3% compared to the prior year period primarily driven by the business mix associated with our new relationships with Corewell Health and Fresenius Medical Care, which include a greater proportion of routine tests than most of our clinical testing.

Excluding the Corewell Health and Fresenius Medical Care business mix impacts, revenue per requisition increased by approximately 2.5% primarily driven by an increase in the number of tests per requisition and favorable test mix.

DIS volume increased by 10.9% compared to the prior year period principally driven by organic growth of 10.8%, of which approximately 7% was due to both our new relationship with Corewell Health to provide Collaborative Lab Solutions and increasing our laboratory testing at dialysis clinics owned by Fresenius Medical Care in the United States.

Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.

Who this business touches

The relationships behind DGX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

FMSFresenius Medical Care AGsupplierFull receipt with Pro →

Depended on by

CAICaris Life Sciences, Inc.supplierFull receipt with Pro →

Filing peers

Companies whose filings use similar operating language.

You can see the shape of the network here. Pro opens 9 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →

What is moving around it

Live connections

DGX is currently a Leader in the organic co-movement group Clinical Diagnostics Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Theme membership history

No durable theme membership has been observed for this name yet.